Hot Pursuit     08-Apr-20
Volumes jump at Zydus Wellness Ltd counter
Zydus Wellness Ltd saw volume of 4863 shares by 10:53 IST on BSE, a 4.7 fold spurt over two-week average daily volume of 1034 shares

Eicher Motors Ltd, Cadila Healthcare Ltd, BEML Ltd, Ipca Laboratories Ltd are among the other stocks to see a surge in volumes on BSE today, 08 April 2020.

Zydus Wellness Ltd saw volume of 4863 shares by 10:53 IST on BSE, a 4.7 fold spurt over two-week average daily volume of 1034 shares. The stock increased 11.68% to Rs.1,470.45. Volumes stood at 4583 shares in the last session.

Eicher Motors Ltd registered volume of 23338 shares by 10:53 IST on BSE, a 4.36 fold spurt over two-week average daily volume of 5351 shares. The stock rose 3.79% to Rs.13,541.15. Volumes stood at 5407 shares in the last session.

Cadila Healthcare Ltd notched up volume of 5.55 lakh shares by 10:53 IST on BSE, a 3.47 fold spurt over two-week average daily volume of 1.60 lakh shares. The stock rose 9.33% to Rs.341.65. Volumes stood at 6.66 lakh shares in the last session.

BEML Ltd saw volume of 59919 shares by 10:53 IST on BSE, a 3.14 fold spurt over two-week average daily volume of 19076 shares. The stock increased 7.83% to Rs.513.00. Volumes stood at 29499 shares in the last session.

Ipca Laboratories Ltd saw volume of 92314 shares by 10:53 IST on BSE, a 3.02 fold spurt over two-week average daily volume of 30579 shares. The stock increased 7.34% to Rs.1,636.00. Volumes stood at 1.05 lakh shares in the last session.

Previous News
  VE Commercial Vehicles records 23% growth in Feb sales
 ( Corporate News - 04-Mar-26   09:32 )
  Eicher Motors motorcycle sales exceed 1 lakh units in Feb'26
 ( Corporate News - 04-Mar-26   09:04 )
  Zydus receives USFDA nod for Ivermectin and Dapsone tablets
 ( Hot Pursuit - 02-Mar-26   11:29 )
  Eicher Motors CV sales climb 23% YoY in February 2026
 ( Hot Pursuit - 02-Mar-26   10:28 )
  Zydus receives USFDA approval for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
 ( Corporate News - 28-Feb-26   11:54 )
  Zydus achieves positive clinical data for Pembrolizumab biosimilar FYB206
 ( Corporate News - 27-Feb-26   19:06 )
  Zydus Lifesciences Ahmedabad injectables unit clears USFDA inspection
 ( Hot Pursuit - 20-Feb-26   10:52 )
  Zydus launches Anyra for treatment of major retinal disorders
 ( Hot Pursuit - 19-Feb-26   10:55 )
  Zydus launches India's first indigenously developed biosimilar - Anyra™
 ( Corporate News - 19-Feb-26   10:52 )
  Zydus receives USFDA approval for Bosentan 32 mg tablets
 ( Corporate News - 18-Feb-26   19:24 )
  Zydus Lifesciences launches PEPAIR, India’s first affordable OPEP device at Rs 990
 ( Hot Pursuit - 17-Feb-26   12:50 )
Other Stories
  IRFC board OKs Rs 70,000 cr borrowing plan for FY27
  09-Mar-26   15:45
  HDFC Life appoints Vijay Vaidyanathan as Chief Human Resource Officer
  09-Mar-26   15:26
  Avenue Supermarts extends gains after multiple DMart store launches
  09-Mar-26   15:17
  PG Electroplast Ltd leads losers in 'A' group
  09-Mar-26   15:00
  Mobavenue AI Tech rallies as board to mull stock-split plan
  09-Mar-26   14:59
  izmo hits the roof after subsidiary enters defence sector as advanced semiconductor packaging partner
  09-Mar-26   14:51
  Sundaram Brake Linings appoints Hari S as CFO
  09-Mar-26   14:49
  Balkrishna Paper Mills Ltd leads losers in 'B' group
  09-Mar-26   14:45
  PG Electroplast drops as supplier flags LPG shortage amid West Asia conflict
  09-Mar-26   14:37
  Volumes soar at Sonata Software Ltd counter
  09-Mar-26   14:30
Back Top